Earnings Mastery
  • Politics
  • Business
  • Investing
  • World
No Result
View All Result
  • Politics
  • Business
  • Investing
  • World
No Result
View All Result
Earnings Mastery
No Result
View All Result
Home Politics

Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain

March 19, 2025
in Politics
Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

A bipartisan group of lawmakers is pushing to reform the incentive structure for Pharmacy Benefit Managers (PBMs), arguing that it drives up patient costs by encouraging them to favor higher-priced drugs while withholding potential savings.

Led by physician and GOP Iowa Rep. Mariannette Miller-Meeks, the group introduced the ‘Delinking Revenue from Unfair Gouging (DRUG) Act’ on Tuesday, requiring that PBMs in the commercial market only charge a flat fee for their services related to a specific prescription drug, versus letting them continue to charge a percentage of the drug price. 

PBMs are third-party intermediaries between insurance companies, drug manufacturers and pharmacies that serve to control drug prices and access. The current incentive structure for PBMs, according to the DRUG Act’s sponsors, encourages them to drive up the list price of drugs to increase profits.    

‘Pharmacy benefit managers (PBMs) have excessive influence over the prices patients pay at the pharmacy counter,’ said Miller-Meeks. ‘Local Iowa pharmacies are closing due to greedy PBM practices, impacting proximity and access to medications for Iowans. The DRUG Act will put downward pressure on prescription drug prices and insurance premiums by removing the incentive for PBMs to drive up the list price of medications.’

According to the Iowa Pharmacy Association, PBMs have been using opaque reimbursement models that often pay back pharmacies less than the list cost of a drug and the services provided to dispense it. 

As a result of these practices, pharmacies in Iowa and across the country have been forced to close, the association said in a January report. Twenty-nine Iowa pharmacies and 2,300 pharmacies nationwide closed their doors in 2024, according to the association.  

While PBMs have played important roles in making drugs more widely available, through decades of mergers and acquisitions, the three largest PBMs now manage nearly 80% of all prescriptions filled in the U.S., according to a 2024 report from the Federal Trade Commission. 

The DRUG Act’s reforms serve to address this anti-competitiveness, which the bill’s sponsors say will also help lower costs.

‘Pharmacy Benefit Managers (PBMs) contribute to high drug costs because they are incentivized to steer patients towards drugs that are more profitable for PBMs, but may be less clinically effective for consumers,’ said Rep. Nannette Barragán, D-Calif., one of the bill’s co-sponsors. ‘This broken system disproportionately harms low-income individuals, seniors, and those with chronic illnesses who rely on life-saving prescriptions to manage their health.’

Rep. Donald Norcross, D-N.J., another co-sponsor of the DRUG Act, said families in his district ‘are crying out for relief from high prescription drug prices.’

‘Americans deserve access to quality health care and affordable prescription drugs,’ Norcross said. ‘The DRUG Act reins in prescription drug prices by removing the incentive for pharmacy benefit managers to drive up costs, increasing transparency and prioritizing patients over profits.’

This post appeared first on FOX NEWS

Previous Post

Trump doesn’t use autopen for legally binding documents, unlike Biden, White House says

Next Post

BT Group share price hits key level: can it surge to 200p?

Next Post
BT Group share price hits key level: can it surge to 200p?

BT Group share price hits key level: can it surge to 200p?

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    Wall Street rallies on US-UK trade breakthrough and China talks optimism; Nasdaq leads gains

    May 9, 2025
    FTSE 100 shares to watch: Aviva, National Grid, Compass, Burberry

    FTSE 100 shares to watch: Aviva, National Grid, Compass, Burberry

    May 9, 2025
    Dollar gains weekly as markets pin hopes on US-China trade talks

    Dollar gains weekly as markets pin hopes on US-China trade talks

    May 9, 2025
    Geopolitical tensions jeopardise energy flows in India and Pakistan

    Geopolitical tensions jeopardise energy flows in India and Pakistan

    May 9, 2025
    Markets fall, defence stocks jump as Indo-Pak tensions flare, but analysts call reaction mild

    Markets fall, defence stocks jump as Indo-Pak tensions flare, but analysts call reaction mild

    May 9, 2025
    Europe markets open: Stoxx 600 points up; focus on Commerzbank earnings, US-China trade outlook

    Europe markets open: Stoxx 600 points up; focus on Commerzbank earnings, US-China trade outlook

    May 9, 2025

    Disclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Popular

    Broadcom shares surge 10% after Q1-print: buy, sell or hold?

    Broadcom shares surge 10% after Q1-print: buy, sell or hold?

    March 8, 2025

    Latest

    Wall Street rallies on US-UK trade breakthrough and China talks optimism; Nasdaq leads gains

    May 9, 2025
    FTSE 100 shares to watch: Aviva, National Grid, Compass, Burberry

    FTSE 100 shares to watch: Aviva, National Grid, Compass, Burberry

    May 9, 2025
    Dollar gains weekly as markets pin hopes on US-China trade talks

    Dollar gains weekly as markets pin hopes on US-China trade talks

    May 9, 2025
    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 earningsmastery.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Business
    • Investing
    • World

    Copyright © 2025 earningsmastery.com | All Rights Reserved